Shanghai Runda Medical Technology Co., Ltd.

XSSC:603108 Stock Report

Market Cap: CN¥10.2b

Shanghai Runda Medical Technology Future Growth

Future criteria checks 3/6

Shanghai Runda Medical Technology is forecast to grow earnings at 94.6% per annum. EPS is expected to grow by 95.3% per annum.

Key information

94.6%

Earnings growth rate

95.3%

EPS growth rate

Life Sciences earnings growth31.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated20 May 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:603108 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20248,43340455754N/A
6/30/20248,761190513802N/A
3/31/20249,042215525819N/A
12/31/20239,147273410730N/A
9/30/20239,751395191452N/A
6/30/202310,255433-411-139N/A
3/31/202310,504457-499-225N/A
12/31/202210,494418-701-429N/A
9/30/20229,854365-577-266N/A
6/30/20229,378336-172155N/A
3/31/20229,008332-61240N/A
12/31/20218,86038070371N/A
9/30/20218,784416-236122N/A
6/30/20218,369422-123244N/A
3/31/20217,79038834398N/A
12/31/20207,069330-8323N/A
9/30/20206,784253-23249N/A
6/30/20206,700246-86162N/A
3/31/20206,820273-333-61N/A
12/31/20197,052310-42247N/A
9/30/20196,821311170452N/A
6/30/20196,464292204481N/A
3/31/20196,200273323574N/A
12/31/20185,964262274539N/A
9/30/20185,72929538288N/A
6/30/20185,351267N/A167N/A
3/31/20184,855242N/A-6N/A
12/31/20174,319219N/A-88N/A
9/30/20173,642199N/A-169N/A
6/30/20173,029164N/A-152N/A
3/31/20172,516134N/A-171N/A
12/31/20162,165116N/A-125N/A
9/30/20161,948115N/A-96N/A
6/30/20161,812105N/A-228N/A
3/31/20161,72195N/A-205N/A
12/31/20151,62992N/A-227N/A
9/30/20151,52892N/A-101N/A
6/30/20151,48384N/A-22N/A
3/31/20151,42081N/A112N/A
12/31/20141,35975N/A36N/A
12/31/20131,02668N/A32N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603108's forecast earnings growth (94.6% per year) is above the savings rate (2.9%).

Earnings vs Market: 603108's earnings (94.6% per year) are forecast to grow faster than the CN market (25% per year).

High Growth Earnings: 603108's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 603108's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 603108's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 603108's Return on Equity is forecast to be high in 3 years time


Discover growth companies